California-based ​​cardiological care company raised an undisclosed amount in a Series F funding round led by GE Healthcare with the participation of new and existing investors. GE Healthcare's President and CEO Tom Westrick will join the board of directors of AliveCor. 

The new funds will be used towards advancing its cardiological care subscription services; KardiaCare, KardiaComplete, and KardiaPro. KardiaCare currently has 130,000 members and offers features to understand and better manage their heart health. KardiaComplete is an enterprise platform for payers, employers, and health systems, to manage their patients' and customers' heart conditions simply using AliveCor technologies. KardiaPro is a physician portal for remote patient monitoring. In addition, the funds will be allocated toward the company’s AI roadmap and pipeline of innovations. 

AliveCor specializes in providing end-end cardiological care and services to diagnose and treat patients. They operate a B2C and B2B2C business model providing services via employers, payers, and physicians. The company’s FDA-cleared KardiaMobile device is built on its own proprietary technology, the AI-enabled machine learning-powered ECG sensors. The ECG solution provides instant detection of atrial fibrillation, bradycardia, tachycardia, sinus rhythm with supraventricular ectopy, sinus rhythm with premature ventricular contractions, sinus rhythm with wide QRS, and normal sinus rhythm. The company has currently served more than two million customers in over 40 countries.